|2001-2005||St. George’s University School of Medicine, Grenada, West Indies. MD received May 2005|
|1995-1998||Butler University College of Pharmacy
Bachelor of Science of Pharmacy
|December 2011||Board Certified in Oncology|
|June 2011||Board Eligible Hematology and Oncology
Planned board exam for November 2011
|June 2010 – June 2011||Indiana University School of Medicine
Indianapolis, INHematology/Oncology Chief Fellow
|2008 – Present||Indiana University School of Medicine
Indianapolis, INHematology/Oncology Fellowship
|October 2008||Board Certification Internal Medicine|
|March 2008||Wishard Hospital
Indiana University School of Medicine
Indianapolis, INInterim Chief Resident
|2006-2008||Indiana University School of Medicine
Indianapolis, INInternal Medicine Residency
|2005-2006||Indiana University School of Medicine
Indianapolis, INInternal Medicine Internship
|Residency/Fellowship||Research Assistant with Professor Asok C.Antony and Prof. H.N. Jayaram, Indiana University School of Medicine, Department of Hematology and Oncology, Indianapolis, IN. Work involved constructing folate-tethered and non-targeted liposomes containing Tiazofurin. liposomes then tested in HD29 and Caco-2 colon cancer cell lines expressing folate receptors. Cytotoxicity studies currently ongoing.
Research with Professor Nasser Hanna, Indiana University School of Medicine, Department of Hematology and Oncology, Indianapolis, IN., involving treatment of extensive Small Cell Lung Cancer. This involved development of a protocol for a randomized, phase II study with Cisplatin plus Etoposide with/without concurrent ZD6474, a novel tyrosine kinase and angiogenesis inhibitor, in patients with previously untreated extensive stage SCLC. Study has funding and protocol is currently pending IRB approval.
|Undergraduate||Indiana University School of Medicine, Indianapolis, IN
Research Assistant with Prof. Arun Srivastava, Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN. Helped in research involving adeno-associated viruses in order to increase the efficiency of gene transfer.
Research Assistant with Prof. H. N. Jayaram, Department of
Research Assistant with Prof. George Weber, Director, Experimental Oncology Laboratory, Indiana University School of Medicine, Indianapolis, IN. Work involved the determination of effect of Tiazofurin, a recent anticancer agent, on IMP dehydrogenase in hepatoma cells.
HONORS / AWARDS
|2010||Poster presentation, ASCO 2010, “The impact of PET imaging on outcomes in patients with stage III non-small cell lung cancer (NSCLC) treated with chemoradiation: A subset analysis of HOG LUN 01-24/USO-023.”
Winner ASCO 2010 Merit Award for above poster presentation.
|March 2008||Winner Best Chairman’s Rounds presentation titled “Erythrocytosis and Polycythemia,” given March 2008.|
|2005||Winner State ACP Abstract competition, 4th place, 2005 for abstract titled “Persistent hiccups as the initial presentation of metastatic colorectal adenocarcinoma” and was given opportunity to present poster at 2005 Indiana Chapter ACP meeting.|
|Member of Iota Epsilon Alpha (IEA) Honor Medical Society|
|December 2001 – December 2005||Dean’s List, St. George’s University School of Medicine|
PUBLICATIONS & PRESENTATIONS
|Hiremagalur N. Jayaram, Kamran Gharehbaghi, Nagesh H. Jayaram, Jason Rieser, Karsten Krohn and Kenneth D. Paull. (1992). Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells. Biochemical and Biophysical Research Communication 186, 1600-1606.Loehrer, Patrick J., Jayaram, Nagesh, Dash, Atreya, Buyyounowski, Mark K., Sharecky, Douglass. “Testicular Cancer.” Cancer Management: A Multidisciplinary Approach. CMPMedica, 2009. 425-448.Kusumanchi P, Zhang Y, Jayaram N, Antony Asok, Jayaram H. Pro-Drug Targeted Gene Therapy for Colorectal Cancer. Brit J Cancer 2010 (in press).Jayaram N, Neubauer M, Johnson CS, Breen T, Williams C, Hanna N. The impact of PET
imaging on outcomes in patients with stage III non-small cell lung cancer (NSCLC) treated with chemoradiation: A subset analysis of HOG LUN 01-24/USO-023. J Clin Oncol 28:7s, 2010 (suppl; abstr 7065), submitted to J Thor Oncol for brief report publication June 2011.
ADDITIONAL PROFESSIONAL ACTIVITIES
|– American Society of Clinical Oncologists (ASCO)- American Society of Hematology (ASH)- American College of Physicians (ACP)|
INTERESTS & ABILITIES
|– Married to Smitha Jayaram, together they have a daughter Aneesha and son Tejas.
– Mountain Biking
– Scuba Diving